118 related articles for article (PubMed ID: 9432034)
1. Quantitative characterization and potential function of membrane Fas/APO-1 (CD95) receptors on leukaemic cells from chronic B and T lymphoid leukaemias.
Kamihira S; Yamada Y; Hirakata Y; Tsuruda K; Sugahara K; Tomonaga M; Maeda T; Tsukasaki K; Atogami S; Kobayashi N
Br J Haematol; 1997 Dec; 99(4):858-65. PubMed ID: 9432034
[TBL] [Abstract][Full Text] [Related]
2. Qualitative and quantitative characterization of Fas (APO-1/CD95) on leukemic cells derived from patients with B-cell neoplasms.
Tsuruda K; Yamada Y; Hirakata Y; Sugahara K; Maeda T; Atogami S; Tomonaga M; Kamihira S
Leuk Res; 1999 Feb; 23(2):159-66. PubMed ID: 10071131
[TBL] [Abstract][Full Text] [Related]
3. Discrepant expression of membrane and soluble isoforms of Fas (CD95/APO-1) in adult T-cell leukaemia: soluble Fas isoform is an independent risk factor for prognosis.
Kamihira S; Yamada Y; Tomonaga M; Sugahara K; Tsuruda K
Br J Haematol; 1999 Dec; 107(4):851-60. PubMed ID: 10606894
[TBL] [Abstract][Full Text] [Related]
4. Soluble and membrane isoforms of Fas/CD95 in fresh adult T-cell leukemia (ATL) cells and ATL-cell lines.
Sugahara K; Yamada Y; Hiragata Y; Matsuo Y; Tsuruda K; Tomonaga M; Maeda T; Atogami S; Tsukasaki K; Kamihira S
Int J Cancer; 1997 Jul; 72(1):128-32. PubMed ID: 9212233
[TBL] [Abstract][Full Text] [Related]
5. Expression and function of the FAS antigen in B chronic lymphocytic leukemia and hairy cell leukemia.
Panayiotidis P; Ganeshaguru K; Foroni L; Hoffbrand AV
Leukemia; 1995 Jul; 9(7):1227-32. PubMed ID: 7543175
[TBL] [Abstract][Full Text] [Related]
6. Clinical relevance of CD95 (Fas/Apo-1) on T cells of patients with B-cell chronic lymphocytic leukemia.
Groneberg C; Pickartz T; Binder A; Ringel F; Srock S; Sieber T; Schoeler D; Schriever F
Exp Hematol; 2003 Aug; 31(8):682-5. PubMed ID: 12901972
[TBL] [Abstract][Full Text] [Related]
7. Role of the CD40 and CD95 (APO-1/Fas) antigens in the apoptosis of human B-cell malignancies.
Wang D; Freeman GJ; Levine H; Ritz J; Robertson MJ
Br J Haematol; 1997 May; 97(2):409-17. PubMed ID: 9163608
[TBL] [Abstract][Full Text] [Related]
8. Chemotherapeutic drug-induced apoptosis in human leukaemic cells is independent of the Fas (APO-1/CD95) receptor/ligand system.
McGahon AJ; Costa Pereira AP; Daly L; Cotter TG
Br J Haematol; 1998 Jun; 101(3):539-47. PubMed ID: 9633899
[TBL] [Abstract][Full Text] [Related]
9. Effects of preactivated autologous T lymphocytes on CD80, CD86 and CD95 expression by chronic lymphocytic leukemia B cells.
Romano C; De Fanis U; Sellitto A; Dalla Mora L; Chiurazzi F; Giunta R; Rotoli B; Lucivero G
Leuk Lymphoma; 2003 Nov; 44(11):1963-71. PubMed ID: 14738151
[TBL] [Abstract][Full Text] [Related]
10. fas-mediated lysis of chronic lymphocytic leukaemia cells: role of type I versus type II cytokines and autologous fasL-expressing T cells.
Williams JF; Petrus MJ; Wright JA; Husebekk A; Fellowes V; Read EJ; Gress RE; Fowler DH
Br J Haematol; 1999 Oct; 107(1):99-105. PubMed ID: 10520029
[TBL] [Abstract][Full Text] [Related]
11. Fas gene mutation in the progression of adult T cell leukemia.
Maeda T; Yamada Y; Moriuchi R; Sugahara K; Tsuruda K; Joh T; Atogami S; Tsukasaki K; Tomonaga M; Kamihira S
J Exp Med; 1999 Apr; 189(7):1063-71. PubMed ID: 10190897
[TBL] [Abstract][Full Text] [Related]
12. Expression of functional Fas antigen on adult T-cell leukemia.
Kotani T; Aratake Y; Kondo S; Tamura K; Ohtaki S
Leuk Res; 1994 Apr; 18(4):305-10. PubMed ID: 7513372
[TBL] [Abstract][Full Text] [Related]
13. Qualitative and quantitative characterization of Fas (CD95) expression and its role in primary human acute leukemia cells.
Li Q; Tsuruda K; Sugahara K; Dateki N; Ohishi E; Yamada Y; Tomonaga M; Moriuchi H; Tsuji Y; Kamihira S
Leuk Res; 2000 May; 24(5):437-44. PubMed ID: 10785266
[TBL] [Abstract][Full Text] [Related]
14. Latent sensitivity to Fas-mediated apoptosis after CD40 ligation may explain activity of CD154 gene therapy in chronic lymphocytic leukemia.
Chu P; Deforce D; Pedersen IM; Kim Y; Kitada S; Reed JC; Kipps TJ
Proc Natl Acad Sci U S A; 2002 Mar; 99(6):3854-9. PubMed ID: 11891278
[TBL] [Abstract][Full Text] [Related]
15. Apoptosis in B-chronic lymphocytic leukaemia.
Osorio LM; Aguilar-Santelises M
Med Oncol; 1998 Dec; 15(4):234-40. PubMed ID: 9951686
[TBL] [Abstract][Full Text] [Related]
16. Proposals for the classification of chronic (mature) B and T lymphoid leukaemias. French-American-British (FAB) Cooperative Group.
Bennett JM; Catovsky D; Daniel MT; Flandrin G; Galton DA; Gralnick HR; Sultan C
J Clin Pathol; 1989 Jun; 42(6):567-84. PubMed ID: 2738163
[TBL] [Abstract][Full Text] [Related]
17. Possible attenuation of fas-mediated signaling by dominant expression of caspase-8 aberrant isoform in adult T-cell leukemia cells.
Sugahara K; Hayashi T; Dateki N; Hirakata Y; Harasawa H; Tomonaga M; Yamada Y; Kamihira S
Int J Hematol; 2002 Jul; 76(1):50-4. PubMed ID: 12138895
[TBL] [Abstract][Full Text] [Related]
18. Aberrant processing of Fas transcripts in adult T-cell leukemia: a possible role in tumor cell survival.
Tawara M; Maeda T; Yamada Y; Harasawa H; Tsuruda K; Sugahara K; Moriuchi R; Tomonaga M; Kamihira S
Cancer Lett; 2003 Apr; 193(2):235-42. PubMed ID: 12706882
[TBL] [Abstract][Full Text] [Related]
19. Mutation of CD95 (Fas/Apo-1) gene in adult T-cell leukemia cells.
Tamiya S; Etoh K; Suzushima H; Takatsuki K; Matsuoka M
Blood; 1998 May; 91(10):3935-42. PubMed ID: 9573032
[TBL] [Abstract][Full Text] [Related]
20. Upstream mediators of the Fas apoptotic transduction pathway are defective in B-chronic lymphocytic leukemia.
Roué G; Lancry L; Duquesne F; Salaün V; Troussard X; Sola B
Leuk Res; 2001 Nov; 25(11):967-80. PubMed ID: 11597732
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
